![Kinneret Livnat Savitsky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kinneret Livnat Savitsky
Directeur/Bestuurslid bij Biomica Ltd.
Actieve functies van Kinneret Livnat Savitsky
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Biomica Ltd.
![]() Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Directeur/Bestuurslid | - | - |
Loopbaan van Kinneret Livnat Savitsky
Eerdere bekende functies van Kinneret Livnat Savitsky
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MabTrix Ltd.
![]() MabTrix Ltd. Pharmaceuticals: MajorHealth Technology MabTrix Ltd. develops biopharmaceutical products. It develops innovative function-blocking therapeutic monoclonal antibody for inflammatory bowel disease. The company was founded in December 2015 and is headquartered in Ness Ziona, Israel. | Directeur/Bestuurslid | 10-05-2018 | - |
Statistieken
Internationaal
Israël | 3 |
Operationeel
Director/Board Member | 2 |
Sectoraal
Commercial Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Biomica Ltd.
![]() Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Commercial Services |
MabTrix Ltd.
![]() MabTrix Ltd. Pharmaceuticals: MajorHealth Technology MabTrix Ltd. develops biopharmaceutical products. It develops innovative function-blocking therapeutic monoclonal antibody for inflammatory bowel disease. The company was founded in December 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |